ArticleInvestigative ophthalmology & visual science2026
Vitrectomy Status Alters Early Intravitreal Drug Distribution: An Ex Vivo PET-CT Study.
Article in Investigative ophthalmology & visual science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: We aimed to evaluate the ex-vivo early-phase spatial drug distribution of intravitreally applied bevacizumab and vancomycin in human and porcine eyes with a native vitreous body compared to vitrectomized eyes filled with balanced salt solution (BSS), silicone oils and a hyaluronic acid-based vitreous body substitute hydrogel. Methods: Porcine eyes were vitrectomized minutes post-mortem and filled with BSS, silicone oil, or hydrogel. Native non-vitrectomized human and porcine eyes served as controls. Intravitreal injections consisted of either bevacizumab or vancomycin labeled with Gallium-68 (68-Ga). Positron emission computer tomography (PET-CT) imaging of cadaver eyes was performed for up to six hours after injection followed by qualitative depiction and quantification of intravitreal distribution of the labeled drugs. Results: Radioactive labeling with 68-Ga and subsequent purification of bevacizumab and vancomycin was successfully applied. Vitrectomized eyes presented an increased early spatial spread of both tested drugs compared to native vitreous body (intravitreal bevacizumab filled volume 36.5% vs. 16.5% [P < 0.0001], intravitreal vancomycin filled volume 31.8% vs. 12.0% [P = 0.0146] after injection). Bevacizumab tended to show a faster diffusion in native vitreous body compared to vancomycin. Bevacizumab appeared not to be soluble in silicone oil. Diffusion within a vitreous body replacement hydrogel is slower compared to BSS-filled eyes in the early phase. Conclusions: Ophthalmic surgical interventions and used endotamponades have a significant impact on early phase spatial diffusion within the vitreous cavity. Based on these preliminary results, early phase diffusion of protein drugs within a hyaluronic acid-based hydrogel is comparable to the native vitreous body.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.